通过ISB 1442对CD38的双相结,可以增加细胞抗体密度和增强细胞活力
Jeremy Loyau1, Thierry Monney1, Marco Montefiori1
1Ichnos Glenmark Innovation, New York, NY, USA.
mAbs
|January 30, 2025
概括
ISB 1442是一种新型双特异性抗体,旨在通过向CD38和CD47来治疗血液癌症. 它独特的双相基结构增强了瘤细胞的结合,并克服了多发性骨髓瘤中的免疫逃避.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 结构生物学 结构生物学
背景情况:
- 多发性骨髓瘤等血液性恶性瘤表达CD38.
- 瘤细胞可以通过CD47信号来逃避免疫检测.
- 双特异性抗体提供有针对性的治疗策略.
研究的目的:
- 描述ISB 1442抗体的发现,优化和表征.
- 通过结构和功能分析,阐明ISB 1442的作用机制.
- 评估ISB 1442对CD38和CD47.7的结合特性和特异性.
主要方法:
- 反CD38的高分辨率共晶结构与CD38. Fabs具有CD38.
- 生物物理测定包括使用多角度光散射 (SEC-MALS) 和表面等离子体共振 (SPR) 的尺寸排除色谱.
- 细胞结合测定和电子显微镜测试以确定抗体-抗原固态度和复合物形成.
主要成果:
- ISB 1442表现出对CD38的双基结合,准非重叠的表位.
- 该抗体与溶液中的CD38形成2:2复合体,通过SEC-MALS和电子显微镜验证.
- 结构和功能数据显示增强的转结合,防止 cis 结合,并增加对 CD38 的嗜好.
结论:
- ISB 1442的双向型设计使得CD38在不同的受体密度上具有优越的准能力.
- 增强的CD38结合促进了近端CD47阻断,抵消了瘤的免疫逃逸.
- ISB 1442显示出治疗CD38+血液性恶性瘤的潜力,包括多发性骨髓瘤.
关键词:
双双特异性抗体 双双特异性抗体CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47这就是为什么CDC CDC CDC.共同晶体结构的共同晶体结构内在细胞调节器的内在细胞调节器.更多相关视频
08:26The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity
Published on: December 14, 2016
15.1K
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
14.0K
相关概念视频
Affinity and Avidity
35.8K
Overview
35.8K
Antibody Actions
1.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.0K
